Quibim secures CE mark for QP-Prostate

2018 08 01 23 13 1733 Artificial Intelligence Ai 400

Quibim has secured the CE mark for QP-Prostate as a class IIB device, as well as receiving UKCA certification.

The company said this allows Quibim to commercialize QP-Prostate in Europe. The device received 510(k) clearance from the U.S. Food and Drug Administration in 2021.

Powered by artificial intelligence, QP-Prostate is an MRI-based software aims to increase diagnostic accuracy and early detection of prostate cancer. The company said it can reduce interpretation time and help define regional diagnosis faster.

Page 1 of 109
Next Page